https://www.nber.org/papers/w20532
Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation | NBER
Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings...
generic competitionand theearly stagepharmaceutical innovationincentives
https://www.econstor.eu/handle/10419/77759
EconStor: Innovation, loyalty and generic competition in pharmaceutical markets
EconStor is a publication server for scholarly economic literature, provided as a non-commercial public service by the ZBW.
generic competitioneconstorinnovationloyaltypharmaceutical
https://www.fool.com/investing/general/2014/01/28/pfizers-adjusted-q4-profit-rises-22-as-generic-com.aspx
Pfizer's Adjusted Q4 Profit Rises 22% as Generic Competition Erodes Top Line | The Motley Fool
Jan 28, 2014 - Share buybacks and cancer drug growth aid Pfizer's fourth-quarter results as generic competition continues to erode its previously best-selling drugs.
https://kffhealthnews.org/morning-breakout/novartis-profits-fall-with-competition-from-generic-cancer-drug/
Novartis Profits Fall With Competition From Generic Cancer Drug - KFF Health News
Apr 21, 2016 - Meanwhile, GlaxoSmithKline is in search of a new CEO and the excitement surrounding a new cholesterol drug is turning into panic over price tag concerns.
https://www.doctorswithoutborders.org/latest/generic-competition-pushing-down-hiv-drug-prices-patents-keep-newer-drugs-unaffordable
Generic Competition Pushing Down HIV Drug Prices, But Patents Keep Newer Drugs Unaffordable |...